Replies to post #534922 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

Thanks for asking. It never hurts to confirm and verify. The SAP was approved by the regulators.

Dr. Ashkan said this in June 2022. Skip to minute 15:25 of the ASCO video.

Dr. Ashkan was the chief investigator of the murcidencel trial for patients in Europe. At King’s College in London, Ashkan is the lead clinician for neuro-oncology and the chair of the King’s Neurosciences Clinical Trial Unit. He is a world-renowned cancer trial expert. A few years ago, Professor Ashkan was named the UK Clinician of the Year by The Brain Tumour Charity. Additionally, Ashkan serves as an advisor to the U.K. government.

https://nwbio.com/wp-content/uploads/jamaoncology_liau_2022_oi_220066_1668698380.80695.pdf